Source: Eur Respir Rev 2013; 22: 3-5



Rating:

Share or cite this content

Citations should be made in the following way:
J. Stuart Elborn. Personalised medicine for cystic fibrosis: treating the basic defect. Eur Respir Rev 2013; 22: 3-5

Member's Comments

No comment yet.

Related content which might interest you: Is cystic fibrosis the hemi-neglected part of respiratory medicine? Source: Virtual Congress 2021 – CCC Thoracic oncology Year: 2021 Advanced cell culture techniques and personalised medicine for cystic fibrosis Source: International Congress 2015 – Respiratory research in the Netherlands Year: 2015 A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases Year: 2021 Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy Source: Breathe, 17 (4) 210112; 10.1183/20734735.0112-2021 Year: 2021 Re-imagining cystic fibrosis care: next generation thinking Source: Eur Respir J, 55 (5) 1902443; 10.1183/13993003.02443-2019 Year: 2020 Personalised CFTR pharmacotherapeutic response testing and therapy of cystic fibrosis Source: Eur Respir J, 51 (6) 1702457; 10.1183/13993003.02457-2017 Year: 2018 The impact of personalised therapies on respiratory medicine Source: Eur Respir Rev 2013; 22: 72-74 Year: 2013 Genomically-guided therapies: a new era for cystic fibrosis Source: Virtual Congress 2020 – European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases Year: 2020 Cystic fibrosis: prospects for therapy of some class 1 mutations Source: Annual Congress 2007 - Cystic fibrosis: will the new biology deliver? Year: 2007 Update on new treatments for cystic fibrosis Source: Virtual Congress 2020 – Updates in cystic fibrosis Year: 2020 The use of telehealth system in improving adherence to nebulised treatment in children with cystic fibrosis: Benefits and pitfalls Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Revisiting α1-antitrypsin therapy in cystic fibrosis: can it still offer promise? Source: Eur Respir J 2007; 29: 229-230 Year: 2007 Medical rehabilitation programme in cystic fibrosis Source: Annual Congress 2009 - Physiotherapy aspects in cystic fibrosis and functional assessment Year: 2009 Implementation of non-medical prescribing within the clinical cystic fibrosis setting Source: International Congress 2014 – Physiotherapy and physical activity in respiratory conditions Year: 2014 Health-economic aspects of cystic fibrosis screening and therapy Source: Eur Respir Monogr 2014; 64: 304-319 Year: 2014 Personalised medicine in interstitial lung diseases Source: Eur Respir Rev, 27 (148) 170117; 10.1183/16000617.0117-2017 Year: 2018 Effect of different physiotherapy devices on ventilation distribution in adults with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 What’s new in cystic fibrosis? Source: International Congress 2018 – Paediatric Year in Review Year: 2018